IITGastric cancer (GC)anti-HER2 therapiesHQM-568GaGa-HQM-5
… tumor specificity, retention, and safety. Crucially, data from IIT confirmed its robust targeting capability in human GC lesions, …
2articles mentioning institutions
4institution mentions
1distinct institutions extracted
0%of mentions human-reviewed
Active filtersEntity: IIT ×
IIT
This institution is selected. Its supporting articles are shown below.
Articles mentioning IIT
2 articles · page 1 of 1IIThematologic malignanciesAutologous CAR-T cell therapiesautoimmune diseasesAID
…production, with a first-in-human investigator-initiated trial (IIT) in China expected to launch soon.…